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ABSTRACT Temperate bacteriophages are a common feature of Pseudomonas aerugi-
nosa genomes, but their role in chronic lung infections is poorly understood. This
study was designed to identify the diverse communities of mobile P. aeruginosa
phages by employing novel metagenomic methods, to determine cross infectivity,
and to demonstrate the influence of phage infection on antimicrobial susceptibility.
Mixed temperate phage populations were chemically mobilized from individual P.
aeruginosa, isolated from patients with cystic fibrosis (CF) or bronchiectasis (BR). The
infectivity phenotype of each temperate phage lysate was evaluated by performing
a cross-infection screen against all bacterial isolates and tested for associations with
clinical variables. We utilized metagenomic sequencing data generated for each
phage lysate and developed a novel bioinformatic approach allowing resolution of
individual temperate phage genomes. Finally, we used a subset of the temperate
phages to infect P. aeruginosa PAO1 and tested the resulting lysogens for their sus-
ceptibility to antibiotics. Here, we resolved 105 temperate phage genomes from 94
lysates that phylogenetically clustered into 8 groups. We observed disease-specific
phage infectivity profiles and found that phages induced from bacteria isolated from
more advanced disease infected broader ranges of P. aeruginosa isolates. Impor-
tantly, when infecting PAO1 in vitro with 20 different phages, 8 influenced antimi-
crobial susceptibility. This study shows that P. aeruginosa isolated from CF and BR
patients harbors diverse communities of inducible phages, with hierarchical infectiv-
ity profiles that relate to the progression of the disease. Temperate phage infection
altered the antimicrobial susceptibility of PAO1 at subinhibitory concentrations of
antibiotics, suggesting they may be precursory to antimicrobial resistance.
IMPORTANCE Pseudomonas aeruginosa is a key opportunistic respiratory pathogen
in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis. The genomes of
these pathogens are enriched with mobile genetic elements including diverse tem-
perate phages. While the temperate phages of the Liverpool epidemic strain have
been shown to be active in the human lung and enhance fitness in a rat lung infec-
tion model, little is known about their mobilization more broadly across P. aerugi-
nosa in chronic respiratory infection. Using a novel metagenomic approach, we iden-
tified eight groups of temperate phages that were mobilized from 94 clinical P.
aeruginosa isolates. Temperate phages from P. aeruginosa isolated from more ad-
vanced disease showed high infectivity rates across a wide range of P. aeruginosa
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genotypes. Furthermore, we showed that multiple phages altered the susceptibility
of PAO1 to antibiotics at subinhibitory concentrations.
KEYWORDS antimicrobial susceptibility, bacteriophages, bronchiectasis, cystic
fibrosis, lysogenic, metagenomics, temperate
Cystic fibrosis (CF) and bronchiectasis (BR) are respiratory diseases that predisposethe individual to chronic infection with opportunistic bacterial pathogens. Pseu-
domonas aeruginosa is a key pathogen in CF and BR that is associated with increased
mortality (1, 2). P. aeruginosa can grow as a biofilm, which aids colonization and likely
worsens outcomes in the chronically infected lung (3). The difficulty in effective delivery
of antibiotics to the lung additionally compromises this treatment, and poor antimi-
crobial pharmacokinetics may contribute to the development of antimicrobial resis-
tance (AMR) (1, 4). P. aeruginosa has a large and flexible genome including a complex
accessory genome (5, 6). Comparative genomics shows that P. aeruginosa genomes
contain a diversity of phage elements that represent a rich source of new genetic
material, including antibiotic resistance genes that may be present and undergo
frequent recombination (6–8). Therefore, temperate phages integrated into the bacte-
rial host genome as a lysogen are likely to play an important roles in P. aeruginosa
evolution as agents facilitating horizontal gene transfer (HGT) of cargo DNA and
additional gene functions. However, changes in integrated phage genomes lead to
deactivation of phage induction, and they are therefore no longer capable of lysis or
onward HGT (9). Remaining phage gene regions may be a rich source of important
gene function and a reservoir for mobilizing phage recombination. The fraction of
integrated temperate phages in P. aeruginosa genomes that remain inducible is un-
known, since this is rarely tested in comparative genomics studies, limiting our under-
standing of the potential for phage mobilization in chronic lung infections.
Previous work on the Liverpool epidemic strain (LES) of P. aeruginosa, which was
isolated from a CF patient, has shown that this strain harbors multiple inducible
temperate phages in its genome (10). These phages remain active and capable of lysis
even after many years of chronic CF lung infection, suggesting that they may play an
important role in the CF lung (11). Experimental infections in both insect and mam-
malian hosts demonstrate that the LES temperate phages increase the fitness of P.
aeruginosa lysogens in vivo, through phage-mediated killing of competing P. aerugi-
nosa strains (12, 13). Furthermore, P. aeruginosa is known to adapt to the lung
environment during chronic infection leading to loss of motility (14), mucoid pheno-
type (15), and biofilm formation (16, 17). The LES temperate phages have been shown
to contribute to this P. aeruginosa evolutionary adaptation in a sputum-like medium by
causing phage insertion-mediated beneficial mutations, particularly in motility and
quorum-sensing-associated genes (18). Given these potentially important contributions
to P. aeruginosa, we need to understand the potential for phage mobilization across a
wider range of clinical P. aeruginosa strains.
Separating individual phage genomes from meta-data is challenging, as related
phages share genomic similarity, which increases the probability of assembling chime-
ric phages. This currently means that it is difficult to characterize phage species at the
genome resolution in a mixed population, which requires isolation and propagation of
individual phages before genomic comparison and characterization can occur. This can
be complicated further by the lack of a receptive bacterial host. We therefore used a
novel metagenomic approach and k-mer abundance strategy to resolve individual
temperate phages that are mobilizing in complexes from P. aeruginosa genomes. This
approach uses the differences in numbers of released phages from the cell during
chemical induction and targets these differences in copy number of phage genomes.
Here, we characterized the diversity of temperate phages induced from a large panel
of P. aeruginosa isolates isolated from patients with either CF or BR. The mobilizable
phages were compared at the genomic level, and infectivity profiles were used to
determine the similarity and differences between CF and BR. Furthermore, we evalu-
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ated the effects of temperate phage infection on the antimicrobial susceptibility of P.
aeruginosa in vitro.
RESULTS
Phage infectivity profiles. Lambdoid-like phages were chemically induced from
each P. aeruginosa isolate using the fluoroquinolone antibiotic norfloxacin. Importantly,
all the clinical P. aeruginosa isolates in this panel contained inducible prophages, which
is a higher proportion than previously reported in other Gram-negative bacteria such
as Escherichia coli (19). Binary networks of phage lysate infectivity against all P.
aeruginosa isolates revealed that CF phages are more broadly infectious than BR
phages (i.e., higher connectance) (Fig. 1A and C). However, interestingly, binary net-
works of BR phage lysates (n 47) had a more nested structure with higher con-
nectance against mucoid BR isolates (n 22) (Fig. 1B and C), suggesting that these
phages were better able to infect mucoid phenotypes than nonmucoid P. aeruginosa
strains. Semisupervised data reduction modeling (PLS-DA) suggested that the phage
lysate infectivity range against P. aeruginosa was greater for phages induced from P.
aeruginosa isolated from more advanced stages of disease in both CF and BR (see
Fig. S1 in the supplemental material). This allowed stratification of the phage lysates
into “early” and “late” disease stages (CF patients were divided into those under the age
16 years or over age 16; BR patients were divided into those less than 10 years since
diagnosis or more than 10 years since diagnosis) for subsequent analyses.
Isolating single phage genomes from mixed phage populations induced from
a clonal bacterial culture using k-mer count and abundance. We used the biology
of temperate phage life cycles and the presumed differences in burst size and diversity
to enable 105 complete individual phage genomes to be resolved from the DNA
sequencing data. With various numbers of phages in each mixed lysate, a method was
implemented to transform the data to distinguish between copy numbers of different
viral genomes to resolve individual phages. The Khmer analysis toolkit (20) uses k-mer
count and abundance to separate data and is normally used to determine the error
k-mer that hinders genome assembly. We modified the python script (calc_median_dis-
tribution.py) in Khmer to allow extraction of individual phage sequences that could be
assembled into single nonchimeric genomes (see the complete method in Text S1 in
the supplemental material) using k-mer distribution. The workflow used to assemble
each phage is summarized in Fig. S2.
Analysis of P. aeruginosa phages in CF and BR. Each of the 105 phages was
assigned to one of 8 groups (A to H) using a genome comparison dot plot method,
Gepard (21) (see Fig. S3). The phage genomes were ordered based on genome
similarity and disease etiology. Figure 2 shows whole-genome phylogenetic compari-
sons aligned with MAFFT, using the L-INS-i algorithm for higher accuracy, which also
shows phylogenetic clustering into 8 groups. Basic local alignment (BLAST) was used to
determine the closest relative within each phylogenetic clade which was labeled
accordingly.
A key aim of this study was to report individual phage genomes; therefore, we only
included single contiguous sequence assemblies in downstream analyses (see Ta-
ble S1). The stringency of our selection criteria removed any phages with fragmented
assemblies or low sequence coverage to allow single phage genome comparisons (for
partial phage genomes identified within the data, see Table S1). Taxonomic assignment
of assembled genomes indicated that Caudovirales phages were enriched in P. aerugi-
nosa isolates in CF and BR (Fig. 2). Groups A to D, F, and G were related to the
Siphoviridae family (n 91), group E was related to the Podoviridae family (n 13), and
group H to the Myoviridae family (n 1). The distributions of phages between the
groups (A to H) and disease etiologies are shown Table S2.
Tables S1 and S2 show both complete and partial genomes determined from the
data. We identified phage group A (F10 like) as the most frequently found group
(n 32) in both disease backgrounds. Group E phages (H66/F116 like) were commonly
identified in BR. In contrast, group D (D3112-like), C (Phi 297-like), and group G (B3-like)
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phages were more frequently found in CF. The Phi297-like phages show genome
homology to D3 and F116, and this is shown in the Gepard plot (Fig. S3) (22).
Interestingly group D phages (D3112 like) (Mu-like transposable phages) (23) and group
C (Phi297 like) were found in the same P. aeruginosa metaviromes, suggesting a
FIG 1 Shows nestedness and connectance plots demonstrating that temperate phages from P. aerugi-
nosa isolated from patients with advanced respiratory infection can infect a wider range of P. aeruginosa
genotypes. The nestedness and connectance plots map the cross-infection data from mixed temperate
phage communities induced from clinical P. aeruginosa isolates. (A) The binary nested network for the
complete 94 phage lysates against 94 P. aeruginosa isolates, ordered by nestedness within equally sized
quadrants (47 CF phages versus 47 CF P. aeruginosa isolates, 47 BR phages versus 47 CF P. aeruginosa
isolates, 47 CF phages versus 47 BR P. aeruginosa isolates, and 47 BR phages versus 47 BR P. aeruginosa
isolates). Each black square represents an individual interaction (infection event) between one phage
strain (x axis) and one bacterial strain (y axis). White squares represent lack of infection. Note the
CF-derived phages are capable of infecting BR P. aeruginosa isolates more frequently than BR phages can
infect CF P. aeruginosa, illustrated through higher values for connectance (0.693). (B) The binary nested
network representation of infection of the mucoid BR P. aeruginosa isolates (n 22) with the entire
cohort of mixed temperate phage communities induced from BR P. aeruginosa isolates (n 47). (C)
Nestedness and connectance values for the results shown in panels A and B.
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FIG 2 Phylogenetic tree of P. aeruginosa phages. The genome assemblies of the 105 P. aeruginosa phages were aligned using MAFFT.
The accuracy method L-INS-i algorithm was used. The phages, grouped by sequence similarity, offer eight clades (A to H). The
(Continued on next page)
Resolving Phage Genomes in Chronic Lung Infections
July/August 2019 Volume 4 Issue 4 e00191-18 msystems.asm.org 5
 o
n
 July 2, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
possible co-lineage. We also identified a cytotoxin-converting PhiCTX-like phage (group
H), which carries the CTX gene; this phage was found in a single BR P. aeruginosa isolate
(24).
Antimicrobial susceptibility of twenty PAO1 lysogens. From each clinical group
(CF, 16 years of age, 16 years; BR, 10 and 10 years since diagnosis), 5 phage
lysates were randomly selected to create P. aeruginosa PAO1 lysogens. Of the 20
lysogens, 8 showed altered antimicrobial susceptibility to clinically relevant antimicro-
bials compared to that of wild-type PAO1 when testing a concentration subinhibitory
to the MIC for PAO1. Figure 3 shows the altered phage-mediated growth of PAO1 in the
presence/absence of ceftazidime (Fig. 3A), colistin (Fig. 3B), meropenem (Fig. 3C), and
piperacillin (Fig. 3D) (25). Seven lysogens significantly decreased the inhibition of
growth to meropenem and piperacillin; one significantly increased inhibition of growth
FIG 2 Legend (Continued)
evolutionary history was inferred using the neighbor-joining method, with the sum of branch length of the optimal tree of 3.04826762.
The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test (1,000 replicates) are shown
next to the branches; the tree was rooted at the midpoint. The evolutionary distances were computed using the p-distance method
and are in the units of the number of base differences per site. All ambiguous positions were removed for each sequence pair. There
were a total of 129,881 positions in the data set. Evolutionary analyses were conducted in MEGA7.
FIG 3 Antimicrobial susceptibility of lysogens to clinically relevant antibiotics. The data shown are after 9 h of incubation: ceftazidime, 0.08 g/ml (A); colistin,
1.6 g/ml (B); meropenem, 0.08 g/ml (C); and piperacillin, 0.8 g/ml (D). *, P  0.05 by one-way ANOVA with Dunnet’s post hoc test for parametric variables
or a one-way ANOVA Kruskal-Wallis test with Dunn’s multiple-comparison test. The lysogens were grouped (and color coded) based on disease etiologies.
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to meropenem. Antibiotic sensitivity was also compared to disease etiology, with only
childhood CF phage PAO1 lysogens showing significant reduction in sensitivity to
meropenem and piperacillin (see Fig. S4). The genomes of the 20 lysogens were
sequenced and compared to that of wild-type PAO1 using Mauve (26) to determine
phage integration sites (see Table S3). Importantly, we found that none of the phages
integrated within putative genes that could be associated with this phenotype. The
specific phage integrated into each site in the PAO1 chromosome is also detailed in
Table S3.
Phage genome search for AMR gene prediction. The 105 phage genomes were
searched using 2 databases (CARD [27] and ARDB [28]) for known and previously
reported AMR genes; none were identified in the phage genomes.
DISCUSSION
This is the largest pan-genome study of P. aeruginosa temperate phages, which
mapped the interactions between phage and bacteria and their broad infectivity across
chronic respiratory disease-related P. aeruginosa isolates. We investigated a broad
range of P. aeruginosa isolates from patients at different stages of disease, and to our
knowledge, this is the largest reported cross-infection study of lysogenic phages
undertaken for clinically derived P. aeruginosa isolates, with over 8,800 infections. We
first showed that P. aeruginosa isolates from these diverse clinical sources have high
levels of inducible phages compared to those of other Gram-negative bacteria (19). This
illustrates a significant reservoir of mobile DNA that could play a major role in bacterial
adaptation and evolution in the lung. This finding combined with a recent study by
Nguyen and colleagues (29) demonstrating that phages are able to interact and
translocate across epithelial surfaces adds a further layer of largely unexplored com-
plexity to chronic respiratory infections.
We found a positive correlation between phage infectivity and disease progression
in both CF and BR, which supports a study by James and colleagues that followed LES
phage populations in LES-infected CF patients over a period of 28 months (11). Our
approach here is more representative of phage induction in the lung, as it utilizes the
infectivity of all the temperate phages, mobilized from each P. aeruginosa genome
under selective pressure. This provides a panoramic snapshot of phage mobilization in
vivo that may illustrate the broad reach of HGT in chronic respiratory disease.
One of our key findings is the hierarchical infectivity of CF- and BR-derived phage
lysates by bipartite ecological network modeling. We saw that chronicity of infection
was associated with greater levels of infectivity. These infectivity profiles supervised by
age and time in CF and BR, respectively, show significant differences that allowed us to
stratify this cross-sectional panel into 2 groups per disease. Previous studies have
demonstrated that P. aeruginosa isolated from CF patients can cross-infect patients
already infected with other P. aeruginosa (30–32), in particular, the Liverpool epidemic
strain (LES). We have previously shown using Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway analysis of these phage metagenomes that the size of the
phage accessory genome increased with the progression of disease. Furthermore, we
identified gene markers that were associated with survival in CF or BR patients with
chronic P. aeruginosa infections (33). Through classifying these phage-host interactions,
we showed the breadth of HGT that would occur on phage induction where we have
previously described the function that can be disseminated directly to the bacterial
host from the phage metagenomes (33). Similar studies have found that temperate
phages mediate pathogen fitness in the lungs of CF patients and demonstrate their
clinical importance in the pathophysiology of the disease (10, 11, 18). The broad
infectivity of phage lysates derived from adult CF patients when infecting P. aeruginosa
from other clinical sources suggests there are additional risks beyond our current
understanding of “bacterial cross-infection,” where phage-mediated HGT adds another
level of complexity.
Importantly, we developed a novel method for resolving individual phage genomes
from metaviromes by modifying a program (Khmer [20]) used to remove the error
Resolving Phage Genomes in Chronic Lung Infections
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k-mer from genome sequencing data. This method has allowed resolution of a variety
of phage genotypes present in chronic respiratory disease-related P. aeruginosa. Given
the importance of transposable phages in driving adaptive evolution of bacterial
pathogens within hosts, the findings of this study highlight a number of temperate
phages to focus on in prospective studies. For example, the group A or F10-like phages
were the most commonly found and more diverse group (n 32) across this panel of
P. aeruginosa; however, despite their prevalence, there is currently limited research on
the biology of these temperate phage (34). Other noteworthy examples include F116-
like phages (group E); these have been shown to easily exchange bacterial chromo-
some genes (35), suggesting it may have a role in bacterial adaptation in the chronically
infected lung. Phi297 has been described as producing halo-morphologies and has a
narrow host range (22); in this study, the Phi297-like phages were predominantly found
in CF isolates and more likely to be associated with a broader infectivity profile.
The phage genomes from group D (D3112 like) and group C (Phi297 like) in our
cohort were intriguingly detected together, a marker that in tandem, they are poten-
tially ecologically important, displaying a symbiotic relationship. We tested this further,
and even when full contiguous sequences of one phages were present, the secondary
phage was always found within the other k-mer peak assemblies.
Kim et al. showed that if P. aeruginosa develops resistance to PA1Ø phage, which
shares genome homology to D3112 (a pilus-infecting phage), then biofilm formation
was reduced, which leads to increased antibiotic susceptibility (36). This provides
evidence that suggests that cocarriage of phages is required and may constitute an
evolutionary advantage, something that has not been previously shown in P. aerugi-
nosa. It is noteworthy that even though each clade relates to a previously described
phage infecting P. aeruginosa, the genomic diversity within each phage group is
extremely high and requires further study.
Current research focuses on identifying genes in bacterial backgrounds and study-
ing the incidence of AMR, which is a key problem in P. aeruginosa infection in CF and
BR. In this study, we demonstrate that phages modulate the growth of the lab strain
PAO1 in the presence of antimicrobials and in the absence of known resistance genes.
We show that 7 of the 20 phages decreased the susceptibility of P. aeruginosa lab strain
PAO1 against one or more of the clinically relevant antipseudomonals and that 1
increased the susceptibility of P. aeruginosa at concentrations below the clinical MIC for
PAO1; yet, the concentration of the antibiotic inhibited the growth of PAO1. Previous
work by Fothergill et al. illustrated differential induction rates and, in some cases,
reduction of phage release when LES P. aeruginosa isolates were challenged with
commonly prescribed antibiotics (37). Microbiome studies of the gut have shown that
antibiotic treatment enriched the phage metagenome and increased transfer of AMR
genes under conditions of physiological stress (38, 39). Importantly we found no
gene(s) associated with these small but significant changes in bacterial susceptibility to
antibiotics using curated CARD and ARDB database searching. We therefore hypothe-
size that this association is mediated by phages and that they subvert normal cellular
and metabolic pathways of P. aeruginosa. This was previously described for phages
transferring genes horizontally in Escherichia coli (40). Here, we showed that phages 24
(CF) and 200 (BR) when integrated into PAO1 as lysogens have the greatest impact
reducing the susceptibility to the antibiotics tested. We propose that a decrease in
susceptibility may increase tolerance, which in turn may progress to AMR (41). Phage
24 is group A (F10 like) and the most heterogeneous compared to the other F10-like
phages isolated here. Similarly, phage 200 is group D (D3112) and integrates at a
different point in the genome than other group D phages. Observationally, phages
associated with earlier stages of disease in CF provide P. aeruginosa with an increased
resistance to antibiotic therapy. Does this mean that these phages are supportive in
early colonization of the CF lung?
To date, there are no treatment algorithms sufficient to meet the demands of these
new clinical challenges. The ability of phages to subvert the physiology of P. aeruginosa
is worrying, especially given the lack of an associated gene target available for
Tariq et al.
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molecular testing. This study highlights an unmet need for further temperate phage P.
aeruginosa studies in patients with CF and BR to understand how phage communities
subvert their bacterial host and impact both microbial fitness and the composition of
the lung microbiota.
MATERIALS AND METHODS
Patient selection. Patients (n 94; 47 cystic fibrosis and 47 non-CF bronchiectasis) were randomly
chosen that were persistently infected with P. aeruginosa and attending specialist clinics at the Newcastle
upon Tyne Hospitals NHS Trust. Ethical approval was obtained from County Durham and Tees Valley
Research ethics committee (REC reference, 12/NE/0248).
Norfloxacin induction of temperate phages. Temperate phages were chemically induced from
bacterial isolates using norfloxacin according to the method previously described (33, 42, 43).
Bacteriophage infectivity assay. Mid-exponential growth phase P. aeruginosa (100 l) was added
to 5 ml 0.4% (wt/vol) LB agar (high clarity agar [Lab M Limited, Heywood, UK] and 1% [wt/vol] 1 M
CaCl2·2H2O [Sigma-Aldrich, Gillingham, UK]) and overlaid onto LB agar 1.5% (wt/vol). Each phage lysate
was serially diluted and spotted onto a lawn of each P. aeruginosa isolate. The plates were incubated at
37°C for 18 h, and the various plaque morphologies were assessed. If a zone of clearing was seen, the
lysates were diluted to define individual plaques to negate clearing due to pyocins.
Modelling of cross-infection data. Bipartite infection networks of bacteria and phage interactions
both within and between diseases were assessed (CF phage versus CF P. aeruginosa, CF phage versus BR
P. aeruginosa, BR phage versus CF P. aeruginosa, and BR phage versus BR P. aeruginosa). Nestedness was
measured using the binary matrix nestedness temperature calculator (binmatnest) (44) within the
“nestedness” metric from the R package bipartite v 2.04 (45, 46). All the binmatnest values given were
statistically significant compared to the associated null model analysis. Network visualizations were
generated using R package bipartite v 2.04. Nestedness is a measure of network order, where a highly
nested pattern describes a hierarchy from generalists (broad host range) to specialists (narrow host
range) for both groups. The binmatnest value is the deviation of the network pattern from an optimal
nested pattern of the same dimensions; values are on a scale from 0 (highly nested) to 100 (not nested
at all). To give these models numerical significance, the nestedness of the interactions was determined.
Construction of a phylogenetic tree. The 105 genome sequences were concatenated into a single
fasta format file and aligned using MAFFT v7 (47). The L-INS-i algorithm was used to improve accuracy.
The alignment file was used to create a p-distance analysis in MEGA7 (48) following construction of a
neighbor-joining tree on p-distance using 1,000 bootstrap analyses.
Generation of twenty P. aeruginosa PAO1 lysogens. Twenty lysogens were generated using 5
randomly chosen phage lysates from each clinical grouping (see patient disease stratification in supple-
mental material) and used to infect PAO1, using an approximate multiplicity of infection of 0.1 (bacteria
to phage, 10:1). Infections were incubated at 37°C for 30 min. Ten microliters of the incubated culture was
inoculated on LB plates and incubated for 18 h at 37°C. Lysogeny was determined through phage
induction from the resulting bacterial colonies and genome sequencing (Illumina, as per phage genome
sequencing) and assembly through de novo reference assemblies using Ragout. The phage integration
sites were tracked using Mauve (26).
Antimicrobial susceptibility profiling of phage-infected PAO1. In conformance with BSAC testing
for Pseudomonas (adapted from reference 49), a 2% inoculum of P. aeruginosa culture with an optical
density at 600 nm (OD600) of 0.03 in a 1:1 ratio with the antibiotics (total volume, 150 l) was used in the
assay. The antipseudomonal antimicrobials used were ceftazidime (Sigma-Aldrich), colistin (Forest Lab-
oratories, London, UK), meropenem (Fresenius Kabi, Runcorn, UK), and piperacillin (Bowmed Ibisqus,
Wrexham, UK). All tests were completed at subinhibitory concentrations of these antibiotics to compare
between the PAO1 and each lysogen. Microtiter plates were incubated at 37°C, 50 rpm to limit biofilm
formation and covered with a breathable seal (AeraSeal Sterile; Alpha Laboratories, Eastleigh, UK).
Absorbance readings (OD600) were taken for the individual wells after 9 h of incubation.
Statistical analyses. All statistical tests were performed with the use of GraphPad Prism 8 (GraphPad,
La Jolla, CA, USA). The distribution of data was determined from a P value of 0.05 using the
Anderson-Darling test. Variations in antibiotic sensitivity between lysogen, PAO1, and antibiotic were
analyzed using a one-way analysis of variance (ANOVA) with Dunnett’s post hoc test for parametric
variables or the one-way ANOVA Kruskal-Wallis test with Dunn’s multiple-comparisons test for nonpara-
metric variables. For all analyses, P values of 0.05 were considered significant.
Phage DNA isolation. Following confirmation of temperate phage presence from the infectivity
assay, the lysate was treated with Turbo DNase (2 U) and RNase (100 U) (Life Technologies Limited) to
remove bacterial chromosomal DNA and incubated at 37°C for 30 min. The enzymes were heat inacti-
vated at 65°C at a final concentration of 15 mM EDTA for 10 min. Norgen Phage DNA isolation kits
(Geneflow Limited, Lichfield, UK) were used to purify the viral DNA.
Genome sequencing. The Illumina Nextera XT (Illumina, Saffron Walden, UK) library preparation kit
was used to prepare 94 individual sequencing libraries relating to each induction and phage DNA
extraction; sequencing was completed using the Illumina MiSeq version 2, 2 250-cycle chemistry.
Paired-end sequencing reads were provided as FASTQ files (NU-OMICS, Northumbria University at
Newcastle, UK). The raw reads had their adapters removed using Trimmomatic (50) and were quality
trimmed using Sickle at –q 30 and –l 15 (51).
k-mer-based sequence separation. The Velvet de novo genome assembler package v1.2.10 shuf-
fleSequences_fastq.pl script was used to randomly shuffle the fastq sequences to limit bias. The shuffled
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sequence output file was directly pipelined into the Khmer toolkit v1.1, which was used for its designed
ability to remove very low-level bacterial contamination and erroneous k-mers from the viral sequence
data. The Khmer count table and k-mer abundance histogram clusters low abundance and poor
sequence data that would be linked to any residual bacterial chromosomal DNA (20). The Khmer
generated k-mer abundance data were graphed in Excel, and the error k-mer peak was manually selected
and removed. The calc-median-distribution.py script part of Khmer (20) was modified and renamed
k-mer_extraction.py (https://github.com/rmadnantariq/k-mer_extraction). The script was altered to se-
lect out the k-mers associated with an abundance peak distribution described in detail in the methods
in the supplemental material.
Phage genome assembly. SPAdes v3.5.0 was used to assemble phage genomes using the careful
parameter, utilizing kmer lengths 21, 33, 55, 77, 99, and 127 (52). The assembled contigs that were
identified as partial were extended using Paired-Read Iterative Contig Extension assembler (PRICE v1.2)
(53). PriceTI was invoked with a minimum overlap of 30 nucleotides using 90% high-quality reads with
90% identity for 51 cycles. The apc script was used to identify circular genomes and remove overlaps
when positive (54), and putatively complete phage genomes were annotated using RASTtk (55–57).
Nucleotide dot plot analysis using Gepard The 105 phage genomes were concatenated together
based on genome similarity and ordered based on disease etiologies. The dot plot was generated with
Gepard (21) using a word size of 10 and sliding window of 25.
Lysogen assembly. CLC genomic workbench v11 was used to generate the assembly of the naive
PAO1 lab strain. This assembly was used as a reference in Ragout post de novo assembly of the lysogens
using SPAdes (v3.5.0). The assemblies were annotated using Prokka v1.22. The naive PAO1 and reference-
assembled PAO1 lysogens were compared using Mauve to track the phage and their insertion sites.
Data availability. All data generated or analyzed during this study are included in the published
article (and its supplemental material files). The raw fastq files were deposited in GenBank with the
BioProject accession PRJNA503342. Resolved 105 phage genome accession numbers can be found in
Table S1.
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